Body Fluid Culture, Mycobacterium (View in report form.)
CERNER / EPIC MNEMONIC:
C AFBSM / C AFB for CSF
CU MYCOBACTERIUM W SMEAR; CU AFB W SMEAR; C AFBSM
87116 (culture); 87206 (smear); 87015
Test includes culture and acid-fast stain (if specimen volume is adequate). If a mycobacterial species is isolated, the organism will be identified. Susceptibility testing will be performed depending upon the isolate identification. Other isolated organisms (i.e. aerobes, yeast, etc.) may be referred for identification and/or susceptibility testing if medically indicated AND a separate culture procedure has NOT yielded the same organism(s).
Smear results: 24 hours after receipt of the specimen in the laboratory. Preliminary culture reports are available after 1 week or when a mycobacterial isolate is detected. Negative cultures with negative smears will be finalized after 8 weeks. Negative cultures with positive smears will be finalized after 12 weeks. Completion of culture reports may require additional time when mycobacteria are isolated and/or susceptibility testing is performed.
The specific anatomic site of the body fluid MUST be specified on the order or requisition.
Sealed sterile container, no preservative
The specimen of choice is an aspirate, NOT a swab. Specimens are to be collected from a site prepared utilizing aseptic technique. Overlying and adjacent areas must be carefully prepared to eliminate surface (normal flora) organisms. Ideally, material obtained by needle aspiration through intact surface which has been cleaned with antiseptic, is put directly into a sealed, sterile container. Contamination with normal flora from skin or other body surfaces must be avoided since colonizing bacteria not involved in the infectious process may be introduced into the sample. Pulmonary samples may be obtained by transtracheal percutaneous needle aspiration.
Aspirated body fluid. Because of the small number of mycobacteria present in most infected body fluids, submission of large volumes, ideally > 5 mL, will improve the sensitivity of culture. This is especially true for CSF specimens. A minimum volume of 10 mL is needed for CSF cultures.
Inappropriate specimen container, insufficient specimen volume, specimen received in a preservative. Only three specimens per body site with negative acid-fast smears will be processed. Subsequent specimens will be rejected. Specimens from known positive patients will be accepted only once a week for culture and smear per body site.
0.5 mL; 1 mL for CSF culture; 10 mL preferred.
Specimen should be transported as soon as possible. When transportation is delayed, refrigerate.
No acid-fast bacilli observed on smear or isolated in culture.
LIMITATIONS OF TEST:
A single negative smear does not rule out the presence of mycobacterial infection.
Due to low sensitivity AFB smears not performed on CSF specimen. Culture: inoculation of conventional culture media and a rapid medium for automated continuous analysis.
DNA probes may be incorporated to aid with more rapid identification of mycobacterial isolates. This will generate an additional charge(s). Susceptibility testing will be performed only on the first Mycobacterium isolate from each specimen type per patient. Additional susceptibilities may be performed after a period of 4 weeks for patients with suspected treatment failure. Susceptibility testing is performed routinely only for M. tuberculosis complex. Susceptibility testing for other Mycobacterium species is performed by special request only. The battery of drugs routinely tested will vary by isolate and/or physician request. Patients from whom M. tuberculosis is isolated in culture are reported to the City of Chicago Board of Health. This is mandated by law.
AFB Culture, Body Fluid; Body Fluid AFB Culture; Body Fluid Culture, TB; Mycobacterium Culture, Body Fluid; TB Culture, Body Fluid